Aspects of immune dysfunction in end-stage renal disease.

By Sawako Kato, M. Chmielewski, H. Honda, R. Pecoits-Filho, S. Matsuo, Y. Yuzawa, A. Tranaeus, P. Stenvinkel, B. Lindholm. American Society of Nephrology. Clinical Journal, 2008

1,023 citations recorded by the source corpus.

Subfields: Nephrology

View Paper: https://www.semanticscholar.org/paper/08093ba24fedce9dab7327e56233488cad03522c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Kitty J. Jager
2. L. J. Tomas
3. P. V. van Dijk
4. F. Rosendaal
5. J. D. De Meester
6. F. Dekker
7. D. Ansell
8. J. Wetzels

Citations in the corpus

• Cardiovascular and noncardiovascular mortality among patients starting dialysis. (2009, background): “Second, uremia in patients receiving dialysis is associated with a state of immune dysfunction characterized by immunoactivation, resulting in inflammation and immunosuppression, which contributes to the high prevalence of infections among such patients.(33) Alterations in the immune system can also”